Median Technologies SA

Paris Stock Exchange ALMDT.PA

Median Technologies SA Price to Earnings Ratio (P/E) on February 05, 2025: -3.16

Median Technologies SA Price to Earnings Ratio (P/E) is -3.16 on February 05, 2025, a -22.19% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Median Technologies SA 52-week high Price to Earnings Ratio (P/E) is -1.58 on April 08, 2024, which is 49.93% above the current Price to Earnings Ratio (P/E).
Median Technologies SA 52-week low Price to Earnings Ratio (P/E) is -6.00 on August 21, 2024, which is -90.21% below the current Price to Earnings Ratio (P/E).
Median Technologies SA average Price to Earnings Ratio (P/E) for the last 52 weeks is -2.95.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Paris Stock Exchange: ALMDT.PA

Median Technologies SA

CEO	Mr. Fredrik Brag
IPO Date	May 20, 2011
Location	France
Headquarters	1800, Route des CrEtes
Employees	250
Sector	Healthcare
Industries Medical Instruments 3D Printing Artificial Intelligence (AI) Big Data Biotechnology Clinical Trials Robotics Telehealth

Description

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.

Key trends

Past 5 years